Brimonidine Tartrate Solution/ Drops
Product Images NDC 0832-1435

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 0832-1435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Brimonidine 01)

Chemical structure of Brimonidine Tartrate, showing the molecular composition including bromine, nitrogen atoms, and the tartrate moiety with carboxyl and hydroxyl groups.*

FDA Label Image

Principal Display Panel (5 mL Bottle Carton)

Box packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%. The label indicates a 5 mL sterile solution for eye use only, labeled for prescription use (Rx only). Manufactured for Upsher-Smith Laboratories, LLC, with storage instructions and inactive ingredients listed. The label includes barcodes and the NDC 0832-1435-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.